+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biologic Therapeutic Drugs: Technologies and Global Markets

  • PDF Icon

    Report

  • 253 Pages
  • January 2024
  • Region: Global
  • BCC Research
  • ID: 5306308
Description Jump to:

The current report offers a detailed picture of the biologics market.



This report highlights the current and future market potential for biologics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2028, as well as key market players.

This report details market shares for biologics based on product, source, application and geography. Based on product, the market is segmented into therapeutic proteins, cell and gene therapy, vaccines, and other segments. Based on application, the market is segmented into cancer, autoimmune conditions, aesthetics, eye disorders, and others. Based on source, the market is segmented into human, animal, micro-organism, fermented cell and others

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2022 as the base year, with forecasts for 2023 through 2028. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes

  • 38 data tables and 59 additional tables
  • An overview of the global markets for biologic therapeutic drugs.
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
  • Estimate of the actual market size and revenue forecast, and a corresponding market share analysis by product type, therapeutic area and region.
  • A discussion of the market’s opportunities and challenges, as well as emerging technologies and regulations.
  • Overview of the sustainability trends, with emphasis on consumer attitudes, companies’ ESG scores, the future of ESG, case studies and the ESG practices of companies.
  • A discussion of the technological means that the leading biopharmaceutical companies are using.
  • Evaluation of the ongoing clinical trials and R&D activity for biologics production.
  • A look at the key drugs on the market and recent approvals, sales statistics and past performance of the top selling biologics, as well as their patent expiries.
  • Review of emerging technologies and patents.
  • An overview of the competitive landscape, including a look at the major vendors’ market shares, recent M&A activity, and venture funding outlook.
  • Company profiles of major players within the industry, including Amgen Inc., Abbive Inc., Eli Lilly And Co., Novartis Ag, and Glaxosmithkline Plc

Table of Contents

Chapter 1 Introduction
  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • What’s New in this Update?
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Segmentation Breakdown
Chapter 2 Summary and Highlights
  • Market Overview
Chapter 3 Market and Technology Background
  • Biopharmaceutical Industry Structure
  • Origins of Biotechnology
  • Involvement of Large Pharmaceutical Companies
  • Overview of Biologics
  • Biologics Manufacturing
  • Biopharmaceutical Manufacturing Process
  • The Preparation Process
  • Expression Systems for Therapeutic Protein Production
  • Advantages of E. coli for Microbial Production
  • Mammalian Cell Therapeutic Protein Production
  • FDA Regulation of Biologics
Chapter 4 Market Dynamics
  • Market Drivers
  • Overview
  • Rising Prevalence of Chronic Diseases
  • Advancement in Biologics
  • Development in Cell and Gene Therapy Methodology
  • Increase in Infectious and Chronic Diseases
  • Market Restraints
  • Emergence of Biosimilars
  • Expensive Cost of Biologics
  • Market Opportunities
  • Opportunities in Emerging Nations
Chapter 5 Market Breakdown by Product Segment
  • Global Market for Biological Therapeutic Drugs by Product
  • Therapeutic Proteins
  • Vaccines
  • Cell and Gene Therapy
  • Others
Chapter 6 Market Breakdown by Application
  • Global Market for Biological Therapeutic Drugs by Application
  • Cancer
  • Autoimmune Conditions
  • Aesthetics
  • Eye Disorder
  • Others
Chapter 7 Market Breakdown by Source
  • Global Market for Biological Therapeutic Drugs by Source
  • Human
  • Animal
  • Microorganisms
  • Fermented Cells
  • Other Sources
Chapter 8 Market Breakdown by Region
  • Global Market for Biological Therapeutic Drugs by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World
  • GCC Countries
  • Brazil
  • Rest of World Countries
Chapter 9 Emerging Technology for Biologics Manufacturing
  • Introduction
  • AcceTT & BacSec Technologies
  • Single-use Technologies
  • Cell and Gene Therapy (CGT)
  • Doggybone DNA (dbDNA)
  • Animal Plasma Isolation
  • Hybridoma Generation
  • B Cell Screening
  • Display Technologies
  • Emerging Biologics Discovery and Generation Technologies
  • Emerging Trends in Biologic Production Technologies
  • Example of New Developments by Companies
  • Samsung Biologics
  • AstraZeneca
  • Genentech Inc. (Member of Roche family)
Chapter 10 Sustainability in the Biopharmaceuticals and Biologics Industry: An ESG Perspective
  • Importance of ESG in the Biopharmaceuticals Manufacturing Industry
  • ESG Ratings and Metrics: Understanding the Data
  • ESG Practices in the Biopharmaceuticals and Biologics Manufacturing Industry
  • Publisher Viewpoint
Chapter 11 M&A and Venture Funding Outlook
  • M&A Analysis
  • M&A Deals 2018-2023
  • Top Biologic Drug Startups
  • Flourishing Biotech Startups (2023)
Chapter 12 FDA Approved Monoclonal Antibodies, 1986-2023
Chapter 13 Competitive Landscape
  • Porter’s Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Threat of Substitutes
  • Competitive Rivalry/Degree of Competition
Chapter 14 Company Profiles
  • ABBVIE INC.
  • AMGEN INC.
  • BAXTER INTERNATIONAL INC.
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CSL LTD.
  • DENDREON PHARMACEUTICALS LLC.
  • ELI LILLY AND CO.
  • F. HOFFMANN-LA ROCHE LTD.
  • GLAXOSMITHKLINE PLC
  • GLYCOTOPE GMBH
  • GRIFOLS S.A.
  • JSC PHARMSTANDARD
  • KEDRION S.P.A.
  • LONZA
  • MERCK & CO. INC.
  • NOVARTIS AG
  • OCTAPHARMA AG
  • RELIANCE LIFE SCIENCES
  • SANOFI
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
List of Tables
Summary Table: Global Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 1: Biologic Orphan Drugs, by Trade Name and Indication
Table 2: Global Cancer Incidence: Both Sexes
Table 3: Approved Cellular and Gene Therapy Products
Table 4: Global Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 5: Global Market for Biological Therapeutic Proteins, by Region, Through 2028
Table 6: Global Market for Biological Therapeutic Vaccines, by Region, Through 2028
Table 7: Global Market for Cell and Gene Therapy, by Region, Through 2028
Table 8: Global Market for Other Biological Therapeutic Drug Products, by Region, Through 2028
Table 9: Global Market for Biological Therapeutic Drugs, by Application, Through 2028
Table 10: Global Market for Biological Therapeutics in Cancer Applications, by Region, Through 2028
Table 11: Global Market for Biological Therapeutics in Autoimmune Condition Applications, by Region, Through 2028
Table 12: Global Market for Biological Therapeutics in Aesthetic Applications, by Region, Through 2028
Table 13: Global Market for Biological Therapeutics in Eye Disorder Applications, by Region Through 2028
Table 14: Global Market for Biological Therapeutics in Other Applications, by Region, Through 2028
Table 15: Global Market for Biological Therapeutic Drugs, by Source, Through 2028
Table 16: Global Market for Human Sources of Biological Therapeutics, by Region, Through 2028
Table 17: Global Market for Animal Sources of Biological Therapeutics, by Region, Through 2028
Table 18: Global Market for Microorganism Sources of Biological Therapeutics, by Region, Through 2028
Table 19: Global Market for Fermented Cell Sources of Biological Therapeutics, by Region, Through 2028
Table 20: Global Market for Other Sources of Biological Therapeutics, by Region, Through 2028
Table 21: Global Market for Biological Therapeutic Drugs, by Region, Through 2028
Table 22: North American Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 23: North American Market for Biological Therapeutic Drugs, by Application Segment, Through 2028
Table 24: North American Market for Biological Therapeutic Drugs, by Source Segment, Through 2028
Table 25: North American Market for Biological Therapeutic Drugs, by Country, Through 2028
Table 26: European Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 27: European Market for Biological Therapeutic Drugs, by Application Segment, Through 2028
Table 28: European Market for Biological Therapeutic Drugs, by Source Segment, Through 2028
Table 29: European Market for Biological Therapeutic Drugs, by Country, Through 2028
Table 30: Asia-Pacific Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 31: Asia-Pacific Market for Biological Therapeutic Drugs, by Application Segment, Through 2028
Table 32: Asia-Pacific Market for Biological Therapeutic Drugs, by Source Segment, Through 2028
Table 33: Asia-Pacific Market for Biological Therapeutic Drugs, by Country, Through 2028
Table 34: Japanese Market Statistics
Table 35: Rest of World Market for Biological Therapeutic Drugs, by Product Segment, Through 2028
Table 36: Rest of World Market for Biological Therapeutic Drugs, by Application Segment, Through 2028
Table 37: Rest of World Market for Biological Therapeutic Drugs, by Source Segment, Through 2028
Table 38: Rest of World Market for Biological Therapeutic Drugs, by Country, Through 2028
Table 39: Brazilian Approved Biologics/Biosimilars, 2023
Table 40: Emerging Trends in Biologics
Table 41: ESG Understanding Data
Table 42: ESG: Environmental Performance
Table 43: ESG: Social Performance
Table 44: ESG: Governance Performance
Table 45: Recently Received Awards by Major Companies
Table 46: ESG Rankings for Major Research Antibody Companies, 2023*
Table 47: U.S. FDA-approved Monoclonal Antibodies in the Market, 2023
Table 48: Porter's Five Forces Analysis
Table 49: AbbVie Inc.: Company Snapshot
Table 50: AbbVie Inc.: Product Portfolio
Table 51: Amgen Inc: Company Snapshot
Table 52: Amgen Inc.: Product Portfolio
Table 53: Baxter International Inc.: Company Snapshot
Table 54: Baxter International Inc.: Product Portfolio
Table 55: Baxter International Inc.: Recent Developments, 2021
Table 56: Boehringer Ingelheim International GmbH: Company Snapshot
Table 57: Boehringer Ingelheim International GmbH: Annual Revenue, 2022
Table 58: Boehringer Ingelheim International GmbH: Products
Table 59: CSL Ltd: Company Snapshot
Table 60: CSL Ltd.: Products Portfolio
Table 61: CSL Ltd.: Recent Developments, 2023
Table 62: Dendreon Pharmaceuticals LLC.: Company Snapshot
Table 63: Dendreon Pharmaceuticals LLC: Product Portfolio
Table 64: Eli Lilly and Co.: Company Snapshot
Table 65: Eli Lilly and Co.: Product Portfolio
Table 66: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 67: F. Hoffmann-La Roche Ltd.: Financials, 2021-2022
Table 68: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 69: GlaxoSmithKline Plc: Company Snapshot
Table 70: GlaxoSmithKline Plc: Products and Services
Table 71: Glycotope GmbH: Company Snapshot
Table 72: Glycotope GmbH: Product Portfolio
Table 73: Grifols S.A.: Company Snapshot
Table 74: Grifols S.A.: Product Portfolio
Table 75: Grifols S.A.: Recent Developments, 2020
Table 76: JSC Pharmstandard: Company Snapshot
Table 77: JSC Pharmstandard: Product Portfolio
Table 78: Kedrion S.p.A.: Company Snapshot
Table 79: Kedrion S.p.A.: Products and Services
Table 80: Kedrion S.p.A.: Recent Developments, 2020
Table 81: Lonza: Company Snapshot
Table 82: Lonza: Product Portfolio
Table 83: Merck & Co. Inc.: Company Snapshot
Table 84: Merck & Co. Inc.: Annual Revenue, 2022
Table 85: Merck & Co. Inc.: Products
Table 86: Novartis AG: Company Snapshot
Table 87: Novartis AG: Product Portfolio
Table 88: Octapharma AG: Company Snapshot
Table 89: Octapharma AG: Products and Services
Table 90: Octapharma AG: Recent Developments, 2020
Table 91: Reliance Life Sciences: Company Snapshot
Table 92: Reliance Life Sciences: Product Portfolio
Table 93: Sanofi: Company Snapshot
Table 94: Sanofi: Products and Services
Table 95: Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 96: Teva Pharmaceutical Industries Ltd.: Product Portfolio
List of Figures
Summary Figure: Global Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 1: Approved Biologics, in 2022
Figure 2: Biological Therapeutic Drugs Market Dynamics
Figure 3: FDA-approved Cell and Gene Therapies
Figure 4: Global Projected Diabetes, Patients Aged 20-79, 2010 and 2030
Figure 5: Global Infectious Diseases Outbreak, between 2020 and 2022
Figure 6: Global Infectious Diseases Outbreak, 2022
Figure 7: Global Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 8: Global Market for Biological Therapeutic Proteins, 2020-2028
Figure 9: Global Market for Biological Therapeutic Proteins, by Region, 2020-2028
Figure 10: Global Market for Biological Therapeutic Vaccines, 2020-2028
Figure 11: Global Market for Biological Therapeutic Vaccines, by Region, 2020-2028
Figure 12: Global Market for Cell and Gene Therapy, 2020-2028
Figure 13: Global Market for Cell and Gene Therapy, by Region, 2020-2028
Figure 14: Investments in Cell and Gene Therapy Companies
Figure 15: Global Market for Other Biological Therapeutic Drug Products, 2020-2028
Figure 16: Global Market for Other Biological Therapeutic Drug Products, by Region, 2020-2028
Figure 17: Global Market Shares of Biological Therapeutic Drugs, by Application, 2022
Figure 18: Global Market for Biological Therapeutics in Cancer Applications, 2020-2028
Figure 19: Global Market for Biological Therapeutics in Cancer Applications, by Region, 2020-2028
Figure 20: Global Market for Biological Therapeutics in Autoimmune Condition Applications, 2020-2028
Figure 21: Global Market for Biological Therapeutics in Autoimmune Condition Applications, by Region, 2020-2028
Figure 22: Global Market for Biological Therapeutics in Aesthetic Applications, 2020-2028
Figure 23: Global Market for Biological Therapeutics in Aesthetic Applications, by Region, 2020-2028
Figure 24: Global Market for Biological Therapeutics in Eye Disorder Applications, 2020-2028
Figure 25: Global Market for Biological Therapeutics in Eye Disorder Applications, by Region, 2020-2028
Figure 26: Global Market for Biological Therapeutics in Other Applications, 2020-2028
Figure 27: Global Market for Biological Therapeutics in Other Applications, by Region, 2020-2028
Figure 28: Global Market Shares of Biological Therapeutic Drugs, by Source, 2022
Figure 29: Global Market for Human Sources of Biological Therapeutics, 2020-2028
Figure 30: Global Market for Human Sources of Biological Therapeutics, by Region, 2020-2028
Figure 31: Global Market for Animal Sources of Biological Therapeutics, 2020-2028
Figure 32: Global Market for Animal Sources of Biological Therapeutics, by Region, 2020-2028
Figure 33: Global Market for Microorganism Sources of Biological Therapeutics, 2020-2028
Figure 34: Global Market for Microorganism Sources of Biological Therapeutics, by Region, 2020-2028
Figure 35: Global Market for Fermented Cell Sources of Biological Therapeutics, 2020-2028
Figure 36: Global Market for Fermented Cell Sources of Biological Therapeutics, by Region, 2020-2028
Figure 37: Global Market for Other Sources of Biological Therapeutics, 2020-2028
Figure 38: Global Market for Other Sources of Biological Therapeutics, by Region, 2020-2028
Figure 39: Global Market for Biological Therapeutic Drugs, by Region, 2020-2028
Figure 40: Global Market Shares of Biological Therapeutic Drugs, by Region, 2022
Figure 41: North American Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 42: North American Market Shares of Biological Therapeutic Drugs, by Application Segment, 2022
Figure 43: North American Market Shares of Biological Therapeutic Drugs, by Source Segment, 2022
Figure 44: North American Market Shares of Biological Therapeutic Drugs, by Country, 2022
Figure 45: U.S. Market for Biological Therapeutic Drugs, 2020-2028
Figure 46: Canadian Market for Biological Therapeutic Drugs, 2020-2028
Figure 47: Mexican Market for Biological Therapeutic Drugs, 2020-2028
Figure 48: European Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 49: European Market Shares of Biological Therapeutic Drugs, by Application Segment, 2022
Figure 50: European Market Shares of Biological Therapeutic Drugs, by Source Segment, 2022
Figure 51: European Market Shares of Biological Therapeutic Drugs, by Country, 2022
Figure 52: German Market for Biological Therapeutic Drugs, 2020-2028
Figure 53: U.K. Market for Biological Therapeutic Drugs, 2020-2028
Figure 54: French Market for Biological Therapeutic Drugs, 2020-2028
Figure 55: Italian Market for Biological Therapeutic Drugs, 2020-2028
Figure 56: Spanish Market for Biological Therapeutic Drugs, 2020-2028
Figure 57: Dupixent Unit Sales by Specialty in Danish Healthcare Region, 2020 and 2021
Figure 58: Rest of European Market for Biological Therapeutic Drugs, 2020-2028
Figure 59: Asia-Pacific Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 60: Asia-Pacific Market Shares of Biological Therapeutic Drugs, by Application Segment, 2022
Figure 61: Asia-Pacific Market Shares of Biological Therapeutic Drugs, by Source Segment, 2022
Figure 62: Asia-Pacific Market Shares of Biological Therapeutic Drugs, by Country, 2022
Figure 63: Chinese Market for Biological Therapeutic Drugs, 2020-2028
Figure 64: Japanese Market for Biological Therapeutic Drugs, 2020-2028
Figure 65: Indian Market for Biological Therapeutic Drugs, 2020-2028
Figure 66: Australia and New Zealand Market for Biological Therapeutic Drugs, 2020-2028
Figure 67: Rest of Asia-Pacific Market for Biological Therapeutic Drugs, 2020-2028
Figure 68: Rest of World Market for Biological Therapeutic Drugs, 2020-2028
Figure 69: Rest of World Market Shares of Biological Therapeutic Drugs, by Product Segment, 2022
Figure 70: Rest of World Market Shares of Biological Therapeutic Drugs, by Application Segment, 2022
Figure 71: Rest of World Market Shares of Biological Therapeutic Drugs, by Source Segment, 2022
Figure 72: Rest of World Market Shares of Biological Therapeutic Drugs, by Country, 2022
Figure 73: GCC Countries Market for Biological Therapeutic Drugs, 2020-2028
Figure 74: Brazilian Market for Biological Therapeutic Drugs, 2020-2028
Figure 75: Rest of Row Countries Market for Biological Therapeutic Drugs, 2020-2028
Figure 76: New Forms of DNA
Figure 77: Snapshot - Key Trends in the Growth of Biologics Production Technologies
Figure 78: Snapshot - Key ESG Trends in Biopharmaceutical and Biologics Industry
Figure 79: Global Manufacturer Market Shares of Biological Therapeutics, 2022
Figure 80: AbbVie Inc.: Annual Revenue, 2020-2022
Figure 81: AbbVie Inc.: Revenue Share, by Products, 2022
Figure 82: AbbVie Inc.: Revenue Share, by Country, 2022
Figure 83: Amgen Inc.: Annual Revenue, 2019-2022
Figure 84: Amgen Inc.: Revenue Share, by Products, 2022
Figure 85: Amgen Inc.: Revenue Share, by Country, 2022
Figure 86: Baxter International Inc.: Annual Revenue, 2019-2022
Figure 87: Baxter International Inc.: Revenue Share, by Business Unit, 2022
Figure 88: Baxter International Inc.: Revenue Share, by Region, 2022
Figure 89: Boehringer Ingelheim International GmbH: Annual Revenue, 2021 and 2022
Figure 90: Boehringer Ingelheim International GmbH: Revenue Shares, by Business Unit, 2022
Figure 91: Boehringer Ingelheim International GmbH: Revenue Shares, by Country/Region, 2022
Figure 92: CSL Ltd.: Financials, 2020-2022
Figure 93: CSL Ltd.: Revenue Share, by Segment, 2022
Figure 94: CSL Ltd.: Revenue Share, by Country/Region, 2022
Figure 95: Eli Lilly and Co.: Annual Revenue, 2020-2022
Figure 96: Eli Lilly and Co.: Revenue Share, by Products, 2022
Figure 97: Eli Lilly and Co.: Revenue Share, by Region, 2022
Figure 98: F. Hoffmann-La Roche Ltd.: Financials, 2021 and 2022
Figure 99: F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, 2022
Figure 100: F. Hoffmann-La Roche Ltd.: Diagnostic Revenue Shares, by Country/Region, 2022
Figure 101: GlaxoSmithKline Plc: Annual Revenue, 2020-2022
Figure 102: GlaxoSmithKline Plc: Revenue Share, by Business Segment, 2022
Figure 103: GlaxoSmithKline Plc: Revenue Share, by Region, 2022
Figure 104: Grifols S.A.: Financials, 2020-2022
Figure 105: Grifols S.A.: Revenues Share, by Segment, 2022
Figure 106: Grifols S.A.: Revenue Share, by Region, 2022
Figure 107: Kedrion S.p.A.: Financials, 2020-2022
Figure 108: Lonza: Annual Revenue, 2020-2022
Figure 109: Lonza: Revenue Shares, by Region, 2022
Figure 110: Lonza: Revenue Shares, by Business Segment, 2022
Figure 111: Merck & Co. Inc.: Revenue Shares, by Business Unit, 2022
Figure 112: Merck & Co. Inc.: Annual Revenue, 2021 and 2022
Figure 113: Merck & Co. Inc.: Revenue Shares, by Country/Region, 2022
Figure 114: Novartis AG.: Annual Revenue, 2020-2022
Figure 115: Novartis AG: Revenue Share, by Region, 2022
Figure 116: Novartis AG: Revenue Share, by Business Segment, 2022
Figure 117: Octapharma AG: Financials, 2020-2022
Figure 118: Sanofi: Annual Revenue, 2020-2022
Figure 119: Sanofi: Revenue Share, by Business Segment, 2022
Figure 120: Sanofi: Revenue Share, by Region, 2019
Figure 121: Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2020-2022
Figure 122: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Segment, 2022
Figure 123: Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2022

Samples

Loading
LOADING...

Executive Summary

The growth of the global market is attributed to the rising prevalence of chronic and acute diseases and the growing level of advancement in biologics production.

The global biologic therapeutic drug market is segmented in this report by product, application, source and region.

Reasons for Doing This Study:

The biologics market is wide-ranging and has important implications for the future of medicine and industry advancement. For companies with an effective strategy, market opportunities await. Importantly, the ability to develop an effective strategy begins where opportunity exists and ends with how to effectively execute a plan to capture profit from such opportunities.

Market growth has been spurred by the need for a more extensive pipeline from drug companies, attractive targets against challenging diseases, a push by companies to pursue biosimilars (a biologic like another biologic that has already been authorized for use) and manufacturing technologies that reduce the cost to produce profitable products.

This report seeks to address the critically important topics of changing market dynamics, emerging players and technologies, strategies for accessing emerging markets, and specific disease segments and geographies to allocate resources and make effective decisions.

Companies Mentioned

  • Abbvie Inc.
  • Amgen Inc.
  • Baxter International Inc.
  • Boehringer Ingelheim International Gmbh
  • Csl Ltd.
  • Dendreon Pharmaceuticals Llc.
  • Eli Lilly And Co.
  • F. Hoffmann-La Roche Ltd.
  • Glaxosmithkline Plc
  • Glycotope Gmbh
  • Grifols S.A.
  • Jsc Pharmstandard
  • Kedrion S.P.A.
  • Lonza
  • Merck & Co. Inc.
  • Novartis Ag
  • Octapharma Ag
  • Reliance Life Sciences
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages253
PublishedJanuary 2024
Forecast Period2023 - 2028
Estimated Market Value ( USD ) in 2023 $ 452.9 Billion
Forecasted Market Value ( USD ) by 2028 $ 823.4 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Biologics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Biologics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 145 Pages
  • Global
From
Wound Care Biologics Market By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Acute Wound, Chronic Wound), By End User (Hospitals and Clinics, Wound Centers and Burn Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Image

Wound Care Biologics Market By Product (Biological Skin Substitutes, Topical Agents), By Wound Type (Acute Wound, Chronic Wound), By End User (Hospitals and Clinics, Wound Centers and Burn Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • 255 Pages
  • Global
From
Biological Drugs: Global Strategic Business Report - Product Image

Biological Drugs: Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Cancer Biologics Market Report 2023-2033 - Product Image

Cancer Biologics Market Report 2023-2033

  • Report
  • 308 Pages
  • Global
From
Neutropenia Biologic Drug Treatment Global Market Report 2024 - Product Image

Neutropenia Biologic Drug Treatment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From

About the Biologic Market

The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share. The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical. Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.